XML 87 R33.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Segment and Enterprise Reporting | 12 Months Ended
--- | ---
Dec. 28, 2024
Segment Reporting [Abstract] |
Segment and Enterprise Reporting | 25. Segment and Enterprise Reporting The Company’s reportable segments are determined based upon the Company’s organizational structure and the way in which the Company’s Chief Operating Decision Maker (CODM), the Company’s interim CEO (as of the end of fiscal year 2024), makes operating decisions, assesses financial performance, and allocates resources. The two segments are: •Healthcare - develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation® solutions and therapeutics. This segment includes the Company’s core legacy hospital business and new Masimo-technology-enabled consumer products that are distributed through many channels including e-commerce sites, leading national retailers and specialty chains globally. •Non-healthcare - designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services, which is currently being evaluated for separation. The Company’s CODM uses segment gross profit, as presented in the Company’s CODM reports, as the primary measure of segment profitability. The significant segment expenses help the Company to better understand operating results. Segment information presented herein reflects the impact of these changes for all periods presented. For the year ended December 28, 2024 and December 30, 2023, intercompany revenues between healthcare and non-healthcare were $4.9 million and $7.7 million, respectively. For the year ended December 31, 2022, there was no intercompany revenue between healthcare and non-healthcare. All inter-segment transactions and balances are eliminated in consolidation for all periods presented below. Selected information by reportable segment is presented below for the years ended December 28, 2024, December 30, 2023 and December 31, 2022:
(in millions) | Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
Revenues by segment: |  |  |  |  |
Healthcare | $ | 1,395.2 |  |  | $ | 1,275.5 |  |  | $ | 1,340.3 |
Non-healthcare | 699.2 |  |  | 772.6 |  |  | 695.5 |
Revenue | $ | 2,094.4 |  |  | $ | 2,048.1 |  |  | $ | 2,035.8 |
Cost of goods sold by segment: |  |  |  |  |
Healthcare | $ | 520.7 |  |  | $ | 498.4 |  |  | $ | 470.1 |
Healthcare other(1) | 80.2 |  |  | 11.5 |  |  | 2.4 |
Non-healthcare | 463.9 |  |  | 514.6 |  |  | 443.0 |
Non-healthcare other(1) | 25.2 |  |  | 20.1 |  |  | 61.5 |
Cost of goods sold | $ | 1,090.0 |  |  | $ | 1,044.6 |  |  | $ | 977.0 |
Gross profit: | $ | 1,004.4 |  |  | $ | 1,003.5 |  |  | $ | 1,058.8 |
Healthcare |  |  |  |  |
Segment gross profit | $ | 874.5 |  |  | $ | 777.1 |  |  | $ | 870.2 |
Acquired asset amortization(1)(2) | (1.8) |  |  | (2.0) |  |  | (2.3) |
Business transition and related costs(1)(3) | (77.1) |  |  | (5.6) |  |  | (0.1) |
Other(1) | (1.3) |  |  | (3.9) |  |  | — |
Non-healthcare |  |  |  |  |
Segment gross profit | 235.3 |  |  | 258.0 |  |  | 252.5 |
Acquired asset amortization(1)(2) | (17.7) |  |  | (19.7) |  |  | (61.5) |
Business transition and related costs(1)(3) | (7.5) |  |  | (0.4) |  |  | — |
__________________ (1) Management excludes certain expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results. (2) Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements. (3) Business transition and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results. The Company’s depreciation and amortization by segment are as follows:
(in millions) | Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
Total depreciation and amortization by segment: |  |  |  |  |
Healthcare | $ | 48.7 |  |  | $ | 38.1 |  |  | $ | 36.0 |
Non-healthcare | 54.3 |  |  | 60.1 |  |  | 100.1 |
Total depreciation and amortization by segment | $ | 103.0 |  |  | $ | 98.2 |  |  | $ | 136.1 |
The Company’s total assets by segment are as follows:
(in millions) | December 28, 2024 |  | December 30, 2023
Total assets by segment: |  |  |
Healthcare | $ | 1,601.1 |  |  | $ | 1,631.8 |
Non-healthcare | 1,007.2 |  |  | 1,390.6 |
Asset held-for-sale | 17.4 |  |  | — |
Corporate overhead | — |  |  | 19.1 |
Total assets by segment | $ | 2,625.7 |  |  | $ | 3,041.5 |
The Company’s consolidated long-lived assets (tangible non-current assets) by geographic area are as follows:
(in millions, except percentages) | Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  |
Total long-lived assets by geographic area: |  |  |  |  |  |  |  |  |  |  |
United States | $ | 319.7 |  |  | 79.9 | % |  | $ | 317.9 |  |  | 74.6 | % |  |  |  |
International | 80.6 |  |  | 20.1 |  |  | 108.0 |  |  | 25.4 |  |  |  |  |
Total long-lived assets by geographic area | $ | 400.3 |  |  | 100.0 | % |  | $ | 425.9 |  |  | 100.0 | % |  |  |  |
The following schedule presents an analysis of the Company’s revenues based upon the geographic area (ship to location):
(in millions, except percentages) | Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
Total revenue by geographic area: |  |  |  |  |  |  |  |  |  |  |
United States (U.S.) | $ | 1,127.6 |  |  | 53.8 | % |  | $ | 1,058.8 |  |  | 51.8 | % |  | $ | 1,141.7 |  |  | 56.1 | %
Europe, Middle East and Africa | 595.6 |  |  | 28.4 |  |  | 571.9 |  |  | 27.9 |  |  | 523.6 |  |  | 25.7 |
Asia and Australia | 303.5 |  |  | 14.5 |  |  | 351.0 |  |  | 17.1 |  |  | 326.8 |  |  | 16.1 |
North and South America (excluding U.S.) | 67.7 |  |  | 3.3 |  |  | 66.4 |  |  | 3.2 |  |  | 43.7 |  |  | 2.1 |
Total revenue by geographic area | $ | 2,094.4 |  |  | 100.0 | % |  | $ | 2,048.1 |  |  | 100.0 | % |  | $ | 2,035.8 |  |  | 100.0 | %

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration